St. Jude Medical’s Market Perform Rating Reaffirmed at BMO Capital Markets (STJ)
St. Jude Medical (NYSE: STJ)‘s stock had its “market perform” rating reiterated by investment analysts at BMO Capital Markets in a note issued to investors on Thursday. They currently have a $40.00 target price on the stock.
St. Jude Medical traded up 0.12% on Thursday, hitting $41.70. St. Jude Medical has a 1-year low of $30.25 and a 1-year high of $44.80. The stock’s 50-day moving average is currently $41.14. The company has a market cap of $12.329 billion and a price-to-earnings ratio of 17.43.
St. Jude Medical last released its earnings data on Wednesday, January 23rd. The company reported $0.92 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.87 by $0.05. The company had revenue of $1.37 billion for the quarter, compared to the consensus estimate of $1.37 billion. During the same quarter in the previous year, the company posted $0.86 earnings per share. The company’s revenue for the quarter was down 2.5% on a year-over-year basis. St. Jude Medical has set its Q1 guidance at $0.91-0.93 EPS and its FY13 guidance at $3.68-3.73 EPS. Analysts expect that St. Jude Medical will post $3.70 EPS for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at TheStreet reiterated a “buy” rating on shares of St. Jude Medical in a research note to investors on Monday. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of St. Jude Medical in a research note to investors on Wednesday, February 27th. They now have a $39.00 price target on the stock. Finally, analysts at Cowen downgraded shares of St. Jude Medical from a “neutral” rating to an “underperform” rating in a research note to investors on Friday, February 15th.
Eleven analysts have rated the stock with a buy rating, two have issued an overweight rating, thirteen have issued a hold rating, and two have issued a sell rating to the company’s stock. The stock has an average rating of “overweight” and an average price target of $43.67.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, April 30th. Shareholders of record on Friday, March 29th will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 2.40%. The ex-dividend date of this dividend is Tuesday, March 26th. This is a positive change from St. Jude Medical’s previous quarterly dividend of $0.23.
St. Jude Medical, Inc. manufactures artificial heart valves. Develops an ambulatory external drug delivery system for insulin and other medications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.